Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB

Emerg Infect Dis. 2012 Apr;18(4):660-3. doi: 10.3201/eid1804.110912.

Abstract

To determine differences in the ability of Mycobacterium tuberculosis strains to withstand antituberculosis drug treatment, we compared the activity of antituberculosis drugs against susceptible Beijing and East-African/Indian genotype M. tuberculosis strains. Beijing genotype strains showed high rates of mutation within a wide range of drug concentrations, possibly explaining this genotype's association with multidrug-resistant tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amikacin / pharmacology
  • Antitubercular Agents / pharmacology*
  • Aza Compounds / pharmacology
  • Bacterial Proteins / genetics
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Fluoroquinolones
  • Genotype
  • Isoniazid / pharmacology
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Mutation
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Quinolines / pharmacology
  • Rifampin / pharmacology
  • Statistics, Nonparametric
  • Tuberculosis, Multidrug-Resistant / microbiology*

Substances

  • Antitubercular Agents
  • Aza Compounds
  • Bacterial Proteins
  • Fluoroquinolones
  • Quinolines
  • Amikacin
  • Moxifloxacin
  • Isoniazid
  • Rifampin